Couverture de 4 or More? Shut the Door! Preventing Migraine Progression

4 or More? Shut the Door! Preventing Migraine Progression

4 or More? Shut the Door! Preventing Migraine Progression

Écouter gratuitement

Voir les détails

À propos de cette écoute

In this second episode of Talking Head Pain: For the Healthcare Professional, our host Erik Stone speaks with Dr. Nina Riggins, a neurologist and leading headache specialist, about the critical role of preventive treatment in migraine care. They unpack common misconceptions among healthcare providers, explore when to start preventive therapies, and discuss how to avoid medication-overuse headache. With a focus on individualized care, health equity, and the latest advances in migraine prevention—such as CGRP-targeted therapies—this episode offers actionable insights to help providers intervene earlier and more effectively.

For more information about the program, and to access the UP-END Migraine initiative—including podcast episodes, video modules, quizzes, and survey insights—visit: ghlf.org/upendmigraine-education.

Meet the Team

Host: Erik Stone, Director of Data, Learning, and Evaluation at GHLF.

A podcast episode produced by Ben Blanc, Director of Digital Production and Engagement at GHLF.

This podcast was made possible with support from Pfizer.

We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org

See omnystudio.com/listener for privacy information.

Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !

    Ce que les auditeurs disent de 4 or More? Shut the Door! Preventing Migraine Progression

    Moyenne des évaluations utilisateurs. Seuls les utilisateurs ayant écouté le titre peuvent laisser une évaluation.

    Commentaires - Veuillez sélectionner les onglets ci-dessous pour changer la provenance des commentaires.

    Il n'y a pas encore de critique disponible pour ce titre.